263 related articles for article (PubMed ID: 34634163)
1. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial.
Piraccini BM; Blume-Peytavi U; Scarci F; Jansat JM; Falqués M; Otero R; Tamarit ML; Galván J; Tebbs V; Massana E;
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):286-294. PubMed ID: 34634163
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
Rossi A; Caro G
J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
[TBL] [Abstract][Full Text] [Related]
4. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
Kaufman KD; Olsen EA; Whiting D; Savin R; DeVillez R; Bergfeld W; Price VH; Van Neste D; Roberts JL; Hordinsky M; Shapiro J; Binkowitz B; Gormley GJ
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
[TBL] [Abstract][Full Text] [Related]
5. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
Gupta AK; Talukder M
J Cosmet Dermatol; 2022 May; 21(5):1841-1848. PubMed ID: 35238144
[TBL] [Abstract][Full Text] [Related]
6. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
[TBL] [Abstract][Full Text] [Related]
7. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
[TBL] [Abstract][Full Text] [Related]
8. Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial.
DuBois J; Bruce S; Stewart D; Kempers S; Harutunian C; Boodhoo T; Weitzenfeld A; Chang-Lin JE
Clin Cosmet Investig Dermatol; 2021; 14():1507-1517. PubMed ID: 34703265
[TBL] [Abstract][Full Text] [Related]
9. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers.
Caserini M; Radicioni M; Leuratti C; Annoni O; Palmieri R
Int J Clin Pharmacol Ther; 2014 Oct; 52(10):842-9. PubMed ID: 25074865
[TBL] [Abstract][Full Text] [Related]
10. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia.
Caserini M; Radicioni M; Leuratti C; Terragni E; Iorizzo M; Palmieri R
Int J Clin Pharmacol Ther; 2016 Jan; 54(1):19-27. PubMed ID: 26636418
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
12. A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia.
Kim H; Ryu C; Lee M; Lee KR; Kim J
Adv Ther; 2024 Jul; 41(7):2936-2952. PubMed ID: 38833144
[TBL] [Abstract][Full Text] [Related]
13. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
15. Finasteride: a review of its use in male pattern hair loss.
McClellan KJ; Markham A
Drugs; 1999 Jan; 57(1):111-26. PubMed ID: 9951956
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair.
Hobo Y; Nishikawa J; Taniguchi Asai N; Yoneyama K; Watanabe Y; Miyashiro Y; Fujikata A
Clin Chim Acta; 2023 Jul; 547():117456. PubMed ID: 37385468
[TBL] [Abstract][Full Text] [Related]
17. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD
J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
[TBL] [Abstract][Full Text] [Related]
18. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ; Dhurat RS
Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
Mella JM; Perret MC; Manzotti M; Catalano HN; Guyatt G
Arch Dermatol; 2010 Oct; 146(10):1141-50. PubMed ID: 20956649
[TBL] [Abstract][Full Text] [Related]
20. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature.
Suchonwanit P; Iamsumang W; Leerunyakul K
J Dermatolog Treat; 2022 Mar; 33(2):643-648. PubMed ID: 32538225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
